These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31427154)

  • 1. Maxillar osteonecrosis related to denosumab. Evaluation of nine cases.
    Sánchez López JD; Cariati P; Pérez de Perceval Tara M
    Med Clin (Barc); 2020 Aug; 155(4):180-181. PubMed ID: 31427154
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 3. Denosumab related osteonecrosis of the jaw: Unusual pattern with periosteal reaction.
    Tagliamento M; Boutros C; Viansone A; Brau JJ; Descols P
    Eur J Cancer; 2022 May; 166():33-37. PubMed ID: 35272085
    [No Abstract]   [Full Text] [Related]  

  • 4. Maxillar osteonecrosis associated to denosumab in a patient with systemic mastocytosis.
    Sánchez López JD; Cariati P; Pérez de Perceval Tara M
    Med Clin (Barc); 2018 Jul; 151(2):81-82. PubMed ID: 29162274
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points.
    Rossi M; Gambino A; Cabras M; Alessio M; Fusco V
    Support Care Cancer; 2021 Aug; 29(8):4185-4186. PubMed ID: 33634351
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication-related osteonecrosis of the jaw; what should we do as prosthodontists?
    Kuroshima S; Kaku M; Matsuura T; Atsuta I; Ayukawa Y; Sawase T
    J Prosthodont Res; 2016 Oct; 60(4):229-230. PubMed ID: 26874926
    [No Abstract]   [Full Text] [Related]  

  • 8. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
    Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
    Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive denosumab-related jaw necrosis - a case series.
    Badr M; Kyriakidou E; Atkins S; Harrison S
    Br Dent J; 2017 Jul; 223(1):13-16. PubMed ID: 28684826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jaw osteonecrosis related to cabozantinib.
    Sánchez López JD; Rodríguez Ruiz JA; Miguel PPT
    Med Clin (Barc); 2021 Jun; 156(12):627-628. PubMed ID: 32883509
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
    Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
    J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral bisphosphonates, denosumab and osteonecrosis of the jaws].
    Cardona Tortajada F; Sainz Gómez E; Viñal Lozano D
    Aten Primaria; 2015 May; 47(5):319-20. PubMed ID: 25523928
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the jaws.
    Toole J
    Rheumatology (Oxford); 2015 Oct; 54(10):1755-6. PubMed ID: 25877909
    [No Abstract]   [Full Text] [Related]  

  • 18. Denosumab-related osteonecrosis of the jaw: a case report and management based on pharmacokinetics.
    You Tm; Lee KH; Lee SH; Park W
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):548-53. PubMed ID: 26337218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis.
    Somay E
    Spec Care Dentist; 2024; 44(2):615-616. PubMed ID: 37515493
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.